Literature DB >> 17981398

Methamphetamine induces alterations on hippocampal NMDA and AMPA receptor subunit levels and impairs spatial working memory.

P F Simões1, A P Silva, F C Pereira, E Marques, S Grade, N Milhazes, F Borges, C F Ribeiro, T R Macedo.   

Abstract

Methamphetamine (METH) is a powerful psychostimulant that increases glutamate (Glu) levels in the mammalian brain and it is currently known that hippocampi are particularly susceptible to METH. Moreover, it is well established that the overactivation of N-methyl-d-aspartate (NMDA) and AMPA ionotropic Glu receptors causes excitotoxicity. In the present study, we investigated the effect of acute (30 mg/kg) versus escalating dose (ED) administration of METH on NMDA receptor 1, NMDA receptor 2 and glutamate receptor 2 (GluR2) subunit expression in the hippocampus and on memory. Adult Sprague-Dawley rats were injected s.c. during six consecutive days with saline (control and acute groups) or with a growing dose of METH (10, 15, 15, 20, 20, 25 mg/kg/day; ED group). On the 7th day, both METH groups were injected with a 'bolus' of 30 mg/kg METH whereas controls received saline. Western blot analysis showed an increase of GluR2 and NR2A expression levels and no alterations on NR1 subunit in the acute group. On the other hand, in the ED group, GluR2 and NR2A expression levels were unaltered and there was a decrease on NR1 levels. Moreover, we did not observe neurodegeneration with both administration paradigms, as assessed by Fluoro-Jade C staining, but we did observe a strong astrogliosis in the acute administration group by using both immunohistochemistry and Western blot analysis. The impact of METH on working memory was evaluated using the Y maze test and revealed significant mnemonic deficit in the rats acutely treated with the drug. Overall, our results suggest a protection mechanism under conditions of METH administration by decreasing permeability and/or functionality of NMDA and AMPA receptors, which has implications on memory. So, the participation of the glutamatergic system should be considered as an important pharmacological target to design new strategies to prevent or diminish the harmful effect of drug consumption.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17981398     DOI: 10.1016/j.neuroscience.2007.09.044

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  32 in total

1.  Impaired memory and reduced sensitivity to the circadian period lengthening effects of methamphetamine in mice selected for high methamphetamine consumption.

Authors:  Reid H J Olsen; Charles N Allen; Victor A Derkach; Tamara J Phillips; John K Belknap; Jacob Raber
Journal:  Behav Brain Res       Date:  2013-08-14       Impact factor: 3.332

Review 2.  GluN2A versus GluN2B: twins, but quite different.

Authors:  Xiao-Min Zhang; Jian-Hong Luo
Journal:  Neurosci Bull       Date:  2013-04-20       Impact factor: 5.203

3.  Distinct neurochemical adaptations within the nucleus accumbens produced by a history of self-administered vs non-contingently administered intravenous methamphetamine.

Authors:  Kevin D Lominac; Arianne D Sacramento; Karen K Szumlinski; Tod E Kippin
Journal:  Neuropsychopharmacology       Date:  2011-10-26       Impact factor: 7.853

4.  Effect of three different regimens of repeated methamphetamine on rats' cognitive performance.

Authors:  Seyedeh Masoumeh Seyedhosseini Tamijani; Elmira Beirami; Abolhassan Ahmadiani; Leila Dargahi
Journal:  Cogn Process       Date:  2017-09-25

5.  Spatial inhibition and the visual cortex: a magnetic resonance spectroscopy imaging study.

Authors:  R Salo; T E Nordahl; M H Buonocore; Y T Natsuaki; C D Moore; C Waters; M H Leamon
Journal:  Neuropsychologia       Date:  2011-01-13       Impact factor: 3.139

6.  Neurochemical and behavioral comparisons of contingent and non-contingent methamphetamine exposure following binge or yoked long-access self-administration paradigms.

Authors:  Catherine A Schweppe; Caitlin Burzynski; Subramaniam Jayanthi; Bruce Ladenheim; Jean Lud Cadet; Eliot L Gardner; Zheng-Xiong Xi; Henriette van Praag; Amy Hauck Newman; Thomas M Keck
Journal:  Psychopharmacology (Berl)       Date:  2020-05-09       Impact factor: 4.530

7.  Methamphetamine-induced toxicity in indusium griseum of mice is associated with astro- and microgliosis.

Authors:  Ana Carmena; Noelia Granado; Sara Ares-Santos; Samuel Alberquilla; Yousef Tizabi; Rosario Moratalla
Journal:  Neurotox Res       Date:  2014-12-10       Impact factor: 3.911

8.  PEGylation of a High-Affinity Anti-(+)Methamphetamine Single Chain Antibody Fragment Extends Functional Half-Life by Reducing Clearance.

Authors:  Emily E Reichard; Nisha Nanaware-Kharade; Guillermo A Gonzalez; Shraddha Thakkar; S Michael Owens; Eric C Peterson
Journal:  Pharm Res       Date:  2016-09-12       Impact factor: 4.200

9.  Effects of a single postnatal methamphetamine administration on NMDA-induced seizures are sex- and prenatal exposure-specific.

Authors:  Romana Slamberová; Barbora Schutová; Iveta Matejovská; Klára Bernásková; Richard Rokyta
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-05-14       Impact factor: 3.000

10.  Distinct roles of methamphetamine in modulating spatial memory consolidation, retrieval, reconsolidation and the accompanying changes of ERK and CREB activation in hippocampus and prefrontal cortex.

Authors:  Guofen Cao; Jie Zhu; Qing Zhong; Chaofeng Shi; Yonghui Dang; Wei Han; Xinshe Liu; Ming Xu; Teng Chen
Journal:  Neuropharmacology       Date:  2012-11-14       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.